h.amankwah

TL2 · Dijon

Contributes reviews on supplier material. Based in Dijon.

Joined 8 June 2025 · last posted 3d

73 posts, newest first. Showing up to 150.

Publication patterns in the BPC-157 literature, examined Replied, post #44 · Compounds › Repair & healing peptides · 25 Jul 2026 · 0 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #21 · Compounds › Oral incretins · 24 Jul 2026 · 0 likes Post #19 and I disagree about the size of the effect, not about the direction. The arithmetic on PIONEER 6 cardiovascular safety is the easy part and it is where the…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #38 · Compounds › Repair & healing peptides · 18 Jul 2026 · 27 likes Post #34 and I disagree about the size of the effect, not about the direction. Where I would push back on the absence of controlled human data consensus is the…
Pages past their review date, listed — does this still hold? Replied, post #55 · Meta › Wiki maintenance · 16 Jul 2026 · 4 likes Taking Pages past seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two…
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #18 · Analytics › Mass spectrometry · 9 Jul 2026 · 2 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory. I…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #68 · Analytics › Home & field testing · 9 Jul 2026 · 0 likes Bookmarking this. I will come back when I have something worth adding.
A structured critique template this community uses — a second dataset Replied, post #27 · Evidence › Study critique · 3 Jul 2026 · 0 likes Fair, and the limits you put on it are the part I will remember.
Alcohol: what is documented and what is folklore Replied, post #81 · Practice › Interactions · 28 Jun 2026 · 4 likes What I can speak to on alcohol is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Insurance and replacement policies, compared Replied, post #46 · Sourcing › Logistics · 27 Jun 2026 · 20 likes On insurance and replacement policies the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
[2026 update] Regional warehouse stock versus direct despatch Replied, post #96 · Sourcing › Logistics · 9 Jun 2026 · 15 likes Everything in post #92 holds. The case it does not cover is the one I have. I would call the community position on Regional warehouse stock versus direct likely rather…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #3 · Practice › Storage & stability · 31 May 2026 · 0 likes Adding the boring version of reconstituted, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations,…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #23 · Compounds › Repair & healing peptides · 9 May 2026 · 11 likes Narrowing post #21, because the general version has more than one answer. Two questions I would want answered before drawing anything from the absence of controlled…
Reading a syringe in poor light, and how to avoid needing to — what changed since Replied, post #5 · Devices › Syringes & needles · 4 May 2026 · 18 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
Coming back to: Measurement error in a self-reported exposure Replied, post #12 · Evidence › Study critique · 23 Apr 2026 · 0 likes On post #11 — agreed on the reasoning, with one qualification. The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is a smaller…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #28 · Practice › Administration · 16 Apr 2026 · 2 likes Note the site alongside the dose. If a local reaction appears three weeks later you will want to know where the previous four injections went. Scoping that to what I…
Follow-up: Sleep quality changes during weight loss Replied, post #3 · Wellbeing › Sleep · 10 Apr 2026 · 0 likes Caffeine and alcohol both affect sleep architecture and both change during a period of reduced intake without anybody deciding to change them. If it helps: the failure…
Revisiting: Drawing up with one needle and injecting with another Replied, post #79 · Practice › Administration · 8 Apr 2026 · 7 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
Spike-and-recover accuracy for a peptide assay Replied, post #21 · Analytics › Method validation · 7 Apr 2026 · 22 likes Post #19 is right about the mechanism and I think understates the practical bit. System suitability is the ongoing evidence that a validated method is still performing.…
Bug report: the reconstitution calculator and a rounding edge case Replied, post #5 · Data & Tools › Calculators · 31 Mar 2026 · 0 likes Understood. Thank you for being specific about the limits of it.
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #50 · Practice › Reconstitution · 21 Mar 2026 · 2 likes Picking up post #47: that is the part I would want checked first. Reading back through the Choosing a concentration threads from last year, the same three questions…
Recording a dissent on a document rather than suppressing it Replied, post #4 · marked as the solution · Documentation › Doc review · 8 Feb 2026 · 7 likes The opening post is the version of this I will quote in future. One addition. Recording a dissent was covered in the wiki last year and the page has a review date on…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #88 · Wellbeing › Mental health · 8 Feb 2026 · 0 likes Support here is genuine and is not a substitute for care, and saying both is not a contradiction.
Trifluoroacetate content and its consequences Replied, post #90 · Analytics › Impurities & related substances · 5 Feb 2026 · 1 like Trifluoroacetate content is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
The most common factual error about semaglutide on the internet — what changed since Replied, post #9 · Compounds › Semaglutide · 17 Jan 2026 · 1 like Answering the question post #8 raises rather than the one it answers. Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #36 · Sourcing › Red flags · 3 Jan 2026 · 8 likes Where I part company with post #32, and it is a narrow parting. Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because…
Oral semaglutide bioavailability and its variability between people Replied, post #24 · Compounds › Oral incretins · 29 Dec 2025 · 4 likes Worth separating two things that post #20 runs together. Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #63 · Compounds › Semaglutide · 6 Dec 2025 · 14 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #24 · Data & Tools › Calculators · 1 Dec 2025 · 12 likes Narrowing post #21, because the general version has more than one answer. Offline use: all calculators are written in JavaScript and can be downloaded and run offline…
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #17 · Compounds › Retatrutide · 18 Nov 2025 · 8 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
Thyroid function tests during substantial weight change Replied, post #124 · Clinical › Bloodwork · 6 Nov 2025 · 0 likes Practical note on thyroid function tests during substantial: write down what you expect before you look. The number of times I have found what I went looking for is…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #9 · Start Here › Welcome · 6 Nov 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
What a purity-only report leaves out Replied, post #23 · Sourcing › Independent verification · 23 Sep 2025 · 30 likes A note on how purity-only gets discussed rather than on purity-only itself: the confident posts get the replies and the careful ones get ignored, and the careful ones…
Can a home kit substitute for a laboratory report? A careful no Replied, post #12 · Analytics › Home & field testing · 15 Sep 2025 · 33 likes I changed my mind about home kit substitute after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
Documenting an adverse event properly Replied, post #3 · Safety › Adverse events · 10 Sep 2025 · 6 likes The arithmetic in post #2 is right; the assumption feeding it is the part to check. Where an event resolved, saying how and how long it took is as useful as the event…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #58 · Data & Tools › Datasets · 8 Sep 2025 · 7 likes No disagreement from me. Posting only so the question does not look ignored.
Confounding by indication, explained with a concrete example Replied, post #10 · Evidence › Study critique · 1 Sep 2025 · 6 likes I had written a reply contradicting post #8 and deleted it. Here is what survived. Defending a paper against criticism: if the authors respond, they might clarify…
Reading SURMOUNT-1 without the press release — one year on Replied, post #5 · Compounds › Tirzepatide · 29 Aug 2025 · 7 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #36 · Evidence › Journal club · 21 Aug 2025 · 12 likes What I want from this orforglipron phase 2 thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #72 · Compounds › Cagrilintide & amylin analogues · 22 Jul 2025 · 13 likes Taking post #71 at face value and following it one step further. What I would want before treating cagrisema phase 2 paper as settled: the method, the sample, and…
Coming back to: What published stability data actually covers, and what it does not Replied, post #85 · Practice › Storage & stability · 12 Jul 2025 · 14 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. It is the sort of…
Half-life, steady state, and accumulation worked through Replied, post #39 · Pharmacology › Pharmacokinetics · 29 May 2025 · 5 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #14 · Pharmacology › Pharmacokinetics · 25 May 2025 · 0 likes The arithmetic in post #11 is right; the assumption feeding it is the part to check. Area under the curve is the exposure measure that matters for most effects in this…
Revisiting: Reading a denial letter as a specification for your appeal Started this topic · Access › Insurance & coverage · 24 May 2025 · 23 likes Posting this under the heading it deserves: Revisiting: Reading a denial letter as a specification for your appeal Everything below is what sits behind that. Asking…
Follow-up: Documentation that appears only after payment Replied, post #72 · Sourcing › Red flags · 13 May 2025 · 0 likes Narrowing post #71, because the general version has more than one answer. Speaking only to Documentation as I have actually seen it, rather than as it is usually…
Cost per milligram, computed honestly across formats — the long version Replied, post #95 · Access › Pricing · 10 May 2025 · 8 likes Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers…
Risk-of-bias tools and the judgement they conceal Replied, post #2 · Evidence › Meta-analyses · 6 May 2025 · 18 likes Speaking only to risk-of-bias tools as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #76 · Compounds › Tirzepatide · 4 May 2025 · 0 likes Post #72 put the caveat in the right place and I want to underline it. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent…
Ipamorelin selectivity claims and where they came from Replied, post #27 · Compounds › Secretagogues & GH axis · 9 Apr 2025 · 10 likes I had written a reply contradicting post #23 and deleted it. Here is what survived. I have three months of notes on ipamorelin selectivity claims and the honest summary…
Follow-up: What other technical communities get right that we do not Replied, post #58 · Lounge › Off topic · 4 Apr 2025 · 20 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #106 · Access › International · 18 Mar 2025 · 8 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
Maintainer handover: how it works Replied, post #38 · Meta › Wiki maintenance · 16 Mar 2025 · 0 likes Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting specific content helps the maintainer prioritise updates. One of…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #119 · Sourcing › Regulatory · 4 Mar 2025 · 4 likes Post #115 and I disagree about the size of the effect, not about the direction. What I would check first on pharmaceutical compounding rules is whether the thing being…
An emergency department visit, described afterwards Started this topic · Safety › Adverse events · 26 Feb 2025 · 0 likes An emergency department visit, described afterwards Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated…
Validating a method you did not develop — does this still hold? Replied, post #45 · Analytics › Method validation · 25 Feb 2025 · 26 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
Talking to a therapist about this specifically — does this still hold? Replied, post #18 · Wellbeing › Mental health · 17 Feb 2025 · 22 likes Nothing here is medical advice and several members in this subcategory say plainly that they are describing their own experience only. Take the reasoning and check the…
When to suspect the method rather than the sample Replied, post #83 · Analytics › Method validation · 16 Feb 2025 · 10 likes The distinction between a qualified instrument and a validated method is worth keeping. Both are needed and they fail in different ways.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #28 · Practice › Reconstitution · 7 Feb 2025 · 21 likes Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every account here of a dosing error involving the wrong concentration…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #8 · Compounds › Tirzepatide · 29 Jan 2025 · 10 likes Confirming post #7 from a second method, which matters more than confirming it from a second person. The number people quote for GIP component of tirzepatide is a…
Protein density versus volume when you cannot eat much Replied, post #29 · Nutrition & Training › Protein & intake · 28 Jan 2025 · 1 like Narrowing post #28, because the general version has more than one answer. The mechanism is not mysterious. Substantial energy restriction with inadequate protein and no…
The topic list is dense — is that deliberate? Replied, post #81 · Meta › Site feedback · 11 Jan 2025 · 9 likes My experience of topic list contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
Building a sensible monitoring schedule with your prescriber Replied, post #100 · Clinical › Bloodwork · 23 Dec 2024 · 0 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. Worth saying I have only my own numbers here, and n…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #11 · Compounds › Semaglutide · 18 Dec 2024 · 25 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #37 · Compounds › Cagrilintide & amylin analogues · 18 Dec 2024 · 2 likes Adding the measurement that post #34 says would settle it. Posting my amylin analogue mechanism numbers with the method attached so they can be discounted properly.…
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #9 · Compounds › Secretagogues & GH axis · 11 Dec 2024 · 32 likes Sermorelin and the growth hormone releasing hormone analogues depend on a functioning pituitary response, which is the mechanistic reason they behave differently in…
Gallbladder disease risk with rapid weight loss Replied, post #40 · Clinical › Comorbidities · 6 Dec 2024 · 10 likes Adding the measurement that post #39 says would settle it. Small correction to my own earlier position on gallbladder disease risk. I had the units the wrong way round,…
Time to steady state after a dose increase Replied, post #14 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 32 likes The arithmetic in post #11 is right; the assumption feeding it is the part to check. Area under the curve is the exposure measure that matters for most effects in this…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #8 · Access › Insurance & coverage · 29 Oct 2024 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #2 · Wellbeing › Mental health · 22 Sep 2024 · 10 likes Offering a way to settle Food noise rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the…
High-resolution MS on aggregates and what it can see — one year on Replied, post #45 · Analytics › Mass spectrometry · 19 Aug 2024 · 10 likes Coming back to post #43, because the follow-up matters more than the original answer. Calibration matters: a high-resolution instrument out of calibration can report…
Guidelines revision: what changed and why Replied, post #81 · Meta › Announcements · 27 Jul 2024 · 30 likes Post #80 put the caveat in the right place and I want to underline it. Thank you for announcing it in advance rather than after. The number of places that do the…
Guidelines revision: what changed and why Replied, post #64 · Meta › Announcements · 27 Jul 2024 · 25 likes Post #61 answers the question as asked. The question underneath it is different. A note on scope: what I am saying about guidelines revision applies to the case in the…
Blind submission and why it changes minds Replied, post #22 · Sourcing › Independent verification · 25 Jul 2024 · 6 likes What I would tell a new member reading about blind submission for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
The mass-error checker and its intended scope Replied, post #14 · Data & Tools › Calculators · 27 May 2024 · 26 likes Saving this. It is the version I will quote when the question comes round again.